Synlett 2016; 27(13): 1993-1996
DOI: 10.1055/s-0035-1561632
letter
© Georg Thieme Verlag Stuttgart · New York

Synthesis of 2-Arylamino-1,3,5-triazines from 2-Aminotriazines with Aryl Halides via CuI-Catalyzed Ullmann Coupling Reaction

Jin Jing Li
a   College of Pharmaceutical Science, Zhejiang University of Technology, Hangzhou 310014, P. R. of China   Email: cuidongmei@zjut.edu.cn
,
Kong Wu
a   College of Pharmaceutical Science, Zhejiang University of Technology, Hangzhou 310014, P. R. of China   Email: cuidongmei@zjut.edu.cn
,
Wei Zhou
a   College of Pharmaceutical Science, Zhejiang University of Technology, Hangzhou 310014, P. R. of China   Email: cuidongmei@zjut.edu.cn
,
Hong Wang
a   College of Pharmaceutical Science, Zhejiang University of Technology, Hangzhou 310014, P. R. of China   Email: cuidongmei@zjut.edu.cn
,
Dong-Mei Cui*
a   College of Pharmaceutical Science, Zhejiang University of Technology, Hangzhou 310014, P. R. of China   Email: cuidongmei@zjut.edu.cn
,
Chen Zhang*
b   School of Pharmaceutical Sciences, Zhejiang University, Hangzhou 310058, P. R. of China
› Author Affiliations
Further Information

Publication History

Received: 12 March 2016

Accepted after revision: 13 April 2016

Publication Date:
13 May 2016 (online)


Abstract

An efficient copper-catalyzed synthesis of 2-arylamino-1,3,5-triazines from 2-aminotriazines with aryl halides under mild conditions has been developed. The reaction occurred in moderate to good yields and tolerated aryl iodides containing functionalities such as nitriles, ethers, amides, and halogens. Aryl bromides were also well tolerated.

Supporting Information

 
  • References and Notes

    • 1a Nishigaki S, Yoneda F, Matsumoto H, Morinaga K. January 1969; 12: 39
    • 1b Goda FE, Tantawy AS, Abou-Zeid LA, Badr SM, Selim KB. Saudi Pharm. J. 2008; 16: 103
    • 1c Chen X, Zhan P, Liu X, Cheng Z, Meng C, Shao S, Pannecouque C, De Clercq E, Liu X. Design Bio. Med. Chem. 2012; 20: 3856
    • 1d Sączewski F, Bułakowska A, Bednarski P, Grunert R. Eur. J. Med. Chem. 2006; 41: 219
    • 2a Chen H, Dao P, Laporte A, Garbay C. Tetrahedron Lett. 2010; 51: 3174
    • 2b Shapiro SL, Isaacs ES, Parrino VA, Freedman L. J. Org. Chem. 1961; 26: 68
    • 2c Alkalay D, Volk J, Barlett MF. J. Pharm. Sci. 1976; 65: 525
    • 2d Chen C, Dagnino R, McCarthy JR. J. Org. Chem. 1995; 60: 8428
    • 3a Dao P, Garbay C, Chen HX. Tetrahedron 2012; 68: 3856
    • 3b Lim J, Simanek EE. Adv. Drug Delivery Rev. 2012; 64: 826
    • 3c Simanek EE, Abdou H, Lalwani S, Lim J, Mintzer M, Venditto VJ, Vittur B. Proc. R. Soc. A 2010; 466: 1445
    • 3d Kim JY. H, Lee JW, Lee WS, Ha H.-H, Vendrell M, Bork JT, Lee Y, Chang Y.-T. ACS Comb. Sci. 2012; 14: 395
    • 3e Blotny G. Tetrahedron 2006; 62: 9507
    • 4a Cahiez G, Moyeux A. Chem. Rev. 2010; 110: 1435
    • 4b Denmark SE, Liu JH.-C. Angew. Chem. Int. Ed. 2010; 122: 3040
    • 4c Evano G, Blanchard N, Toumi M. Chem. Rev. 2008; 108: 3054
    • 4d Torborg C, Beller M. Adv. Synth. Catal. 2009; 351: 3027
    • 4e Weber J, Thomas A. J. Am. Chem. Soc. 2008; 130: 6334
    • 5a Ullmann F. Ber. Dtsch. Chem. Ges. 1903; 36: 2382
    • 5b Ma D, Zhang Y, Yao J, Wu S, Tao F. J. Am. Chem. Soc. 1998; 120: 12459
    • 5c Lang F, Zewge D, Houpis I, Volante RP. Tetrahedron Lett. 2001; 42: 3251
    • 5d Goldberg I. Ber. Dtsch. Chem. Ges. 1906; 39: 1691

      For examples of N-arylation reaction, see:
    • 6a Lawson CP. A. T, Slawin AM. Z, Westwood NJ. Chem. Commun. 2011; 47: 1057
    • 6b Ma D, Cai Q. Acc. Chem. Res. 2008; 41: 1450
    • 6c Monnier F, Taillefer M. Angew. Chem. Int. Ed. 2008; 47: 3096
    • 6d Jiang L, Job GE, Klapars A, Buchwald SL. Org. Lett. 2003; 5: 3667
    • 6e Ley SV, Thomas AW. Angew. Chem. Int. Ed. 2003; 42: 5400
  • 7 Dao P, Garbay C, Chen HX. Tetrahedron 2012; 68: 3856
  • 8 Typical Experimental Procedure: To a mixture of 1,3,5-triazine (0.5 mmol), aryl halide (0.5 mmol), DMEDA (0.45 mmol) and K2CO3 (1 mmol) in MeCN (3 mmol) was added CuI (0.15 mmol). The resulting mixture was stirred at reflux. After completion of the reaction, the reaction mixture was cooled to r.t., concd NH3 (4 mL) and sat. NaCl (10 mL) were added, and the organic phase was then extracted with EtOAc (3 × 15 mL). The organic phase was dried over anhyd Na2SO4. The crude residue was obtained after evaporation of the solvent in vacuum, and the residue was purified by flash chromatography with petroleum and EtOAc as the eluent to give the pure product. N 2-(4-Methoxyphenyl)-N 4,N 4-dimethyl-6-phenyl-1,3,5-triazine-2,4-diamine (3a): white solid; mp 166–167 °C. 1H NMR (500 MHz, CDCl3): δ = 8.43 (dd, J = 8.2, 1.4 Hz, 2 H), 7.58 (d, J = 9.0 Hz, 2 H), 7.46–7.53 (m, 3 H), 7.17 (br, 1 H), 6.91 (d, J = 9.0 Hz, 2 H), 3.83 (s, 3 H), 3.34 (s, 3 H), 3.23 (s, 3 H). 13C NMR (125 MHz, CDCl3): δ = 170.6, 165.9, 164.5, 155.6, 137.4, 132.4, 131.3, 128.4, 128.2, 121.8, 114.1, 55.6, 36.4. IR (KBr): 3353, 3066, 2944, 1604, 1506, 1211, 1039, 829, 778, 704 cm–1. HRMS (ESI): m/z [M + H]+ calcd for C18H20N5O: 322.1668; found: 322.1684. N 2-(4-Methoxyphenyl)-N 4,N 4-dimethyl-1,3,5-triazine-2,4-diamine (3s): white solid; mp 161–163 °C. 1H NMR (500 MHz, CDCl3): δ = 8.40 (br, 1 H), 8.25 (s, 1 H), 7.50 (d, J = 8.2 Hz, 2 H), 6.88 (d, J = 8.2 Hz, 2 H), 3.80 (s, 3 H), 3.19 (s, 3 H), 3.16 (s, 3 H). 13C NMR (125 MHz, CDCl3): δ = 165.3, 164.5, 163.3, 155.8, 131.8, 122.3, 114.0, 55.5, 36.3. IR (KBr): 3434, 3195, 2951, 1613, 1512, 1197, 1037, 831, 805 cm–1. HRMS (ESI): m/z [M + H]+ calcd for C12H16N5O: 246.1355; found: 246.1377. 4-Morpholino-N-(4-nitrophenyl)-6-phenyl-1,3,5-triazin-2-amine (3u): yellow solid; mp 277–278 °C. 1H NMR (500 MHz, DMSO-d 6): δ = 10.41 (s, 1 H), 8.39 (dd, J = 8.5, 1.5 Hz, 2 H), 8.23 (d, J = 9.2 Hz, 2 H), 8.05 (d, J = 9.2 Hz, 2 H), 7.57–7.61 (m, 1 H), 7.52–7.58 (m, 2 H), 3.95 (br, 2 H), 3.83 (br, 2 H), 3.68–3.76 (m, 4 H). 13C NMR (125 MHz, DMSO-d 6): δ = 170.3, 164.5, 164.3, 146.5, 141.1, 136.2, 132.0, 128.5, 128.2, 124.9, 119.1, 65.9, 43.6. IR (KBr): 3310, 2950, 2858, 1606, 1497, 1332, 1270, 1215, 1107, 846, 779, 701 cm–1. HRMS (ESI): m/z [M + H]+ calcd for C19H19N6O3: 379.1519; found: 379.1524. N 2-(4-Methoxyphenyl)-N 4,6-diphenyl-1,3,5-triazine-2,4-diamine (3v): white solid; mp 143–145 °C. 1H NMR (500 MHz, CDCl3): δ = 8.44 (d, J = 7.3 Hz, 2 H), 7.65 (d, J = 6.4 Hz, 2 H), 7.49–7.58 (m, 5 H), 7.46 (br, 2 H), 7.35 (t, J = 7.3 Hz, 2 H), 7.11 (t, J = 7.4 Hz, 1 H), 6.92 (d, J = 8.4 Hz, 2 H), 3.84 (s, 3 H). 13C NMR (125 MHz, CDCl3): δ = 171.7, 164.9, 164.7, 156.2, 138.5, 136.5, 131.8, 131.3, 128.9, 128.4, 123.4, 123.0, 122.9, 120.5, 114.1, 55.6. IR (KBr): 3338, 3061, 2832, 1597, 1516, 1244, 1208, 1036, 826, 777, 756, 700 cm–1. HRMS (ESI): m/z [M + H]+ calcd for C22H20N5O: 370.1668; found: 370.1671.